Scientists in the United States are carrying out research using embryonic stem cells in a bid to offer help for people suffering from type 1 diabetes .
The team, from a company based in San Diego called ViaCyte Inc. have developed a new kind of medical implant that assists diabetic patients in managing their blood sugar levels . The method consists of a type of envelope filled with embryonic stem cells and implanted under the skin, so that the cells involved become pancreatic cells .
People who have type 1 diabetes usually need insulin injections or an insulin pump to control their blood sugar, although this approach can be inconvenient and difficult to stick to. Eugene Brando, a director at ViaCyte, has claimed that the device has already been used to successfully treat diabetes in mice. He commented on the research, “We’re essentially creating a replacement pancreas .”
However, Vivian Fonsecan, president-elect for medicine and science at the American Diabetes Associatio, also said “What people want is a single, one-time cure. I don’t see that happening in the foreseeable future”, although he argued that stem cell research could be a step in the right direction.
The company plans to start human trials by 2013, funded by the California Institute of Regenerative Medicine, the state’s stem cell funding agency.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Twice daily dairy intakes could reduce type 2 diabetes risk

Eating cheese, yoghurt or eggs twice a day could help lower the…

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Coronavirus: UK instructed to stay at home this weekend

Health Secretary Matt Hancock has said that staying at home this weekend…